Search | IOVS | ARVO Journals

Showing 1 – 18 of 18

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2017

Association between IOP and retinal thickness following intravitreal triamcinolone injections in DME patients

Mohammad Dahrouj; Jan A Kylstra; Bethany Wolf; Zsolt Ablonczy; Craig E Crosson

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):243. doi:

Retina May 2016

Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats

PDF

Danielle M. Desjardins; Phil W. Yates; Mohammad Dahrouj; Yueying Liu; Craig E. Crosson; Zsolt Ablonczy
TAGS: vascular endothelial growth factor a, diabetes mellitus, hyperglycemia, injection of therapeutic agent, streptozocin, rats, hyperglycemic agent, retinal pigment epithelium
Invest. Ophthalmol. Vis. Sci.. 2016; 57(6):2706-2713. doi: 10.1167/iovs.15-18397

ARVO Annual Meeting Abstract June 2015

The hyperglycemia-induced early retinal pigment epithelium dysfunction is mediated by vascular endothelial growth factor

Zsolt Ablonczy; Danielle Desjardins; Mohammad Dahrouj; Yueying Liu; Kumar Sambamurti; Craig E Crosson

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5176. doi:

Glaucoma November 2014

Acetylation Preserves Retinal Ganglion Cell Structure and Function in a Chronic Model of Ocular Hypertension

PDF

Oday Alsarraf; Jie Fan; Mohammad Dahrouj; C. James Chou; Phillip W. Yates; Craig E. Crosson
TAGS: acetylation, histone deacetylase, ocular hypertension, retinal ganglion cells, eye, retina, valproic acid
Invest. Ophthalmol. Vis. Sci.. 2014; 55(11):7486-7493. doi: 10.1167/iovs.14-14792

ARVO Annual Meeting Abstract April 2014

RPE barrier dsyfunction is an early complication in the diabetic eye

Zsolt Ablonczy; Danielle Desjardins; Mohammad Dahrouj; Yueying Liu; Kumar Sambamurti; Shahid Husain; Craig E Crosson

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1048. doi:

ARVO Annual Meeting Abstract April 2014

Trichostatin A abrogates advanced glycation end-product-induced retinal pigment epithelium dysfunction in an in vivo model of diabetic eye disease

Danielle Desjardins; Mohammad Dahrouj; Yueying Liu; Zsolt Ablonczy; Craig E Crosson

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1055. doi:

ARVO Annual Meeting Abstract April 2014

Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels

Alexander Georg Marneros; Mohammad Dahrouj; Zsolt Ablonczy

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):1189. doi:

ARVO Annual Meeting Abstract April 2014

CNP reverses AGE effects on RPE by Acting Downstream from VEGF Release

Mohammad Dahrouj; Yueying Liu; Craig E Crosson; Zsolt Ablonczy

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3027. doi:

Physiology and Pharmacology April 2014

Vascular Endothelial Growth Factor Modulates the Function of the Retinal Pigment Epithelium In Vivo

PDF

Mohammad Dahrouj; Oday Alsarraf; Jake C. McMillin; Yueying Liu; Craig E. Crosson; Zsolt Ablonczy
TAGS: vascular endothelial growth factor a, albumins, blister, retinal pigment epithelium
Invest. Ophthalmol. Vis. Sci.. 2014; 55(4):2269-2275. doi: 10.1167/iovs.13-13334

Biochemistry and Molecular Biology August 2013

Lack of Correlation Between the Spatial Distribution of A2E and Lipofuscin Fluorescence in the Human Retinal Pigment Epithelium

PDF

Zsolt Ablonczy; Daniel Higbee; David M. Anderson; Mohammad Dahrouj; Angus C. Grey; Danielle Gutierrez; Yiannis Koutalos; Kevin L. Schey; Anne Hanneken; Rosalie K. Crouch
TAGS: fluorescence, lipofuscin, spectrometry, mass, matrix-assisted laser desorption-ionization, body tissue, diagnostic imaging, eye, retinal pigment epithelium
Invest. Ophthalmol. Vis. Sci.. 2013; 54(8):5535-5542. doi: 10.1167/iovs.13-12250

ARVO Annual Meeting Abstract June 2013

Natriuretic peptides regulate MAP kinases via PKG to protect the RPE from VEGF action

Zsolt Ablonczy; Mohammad Dahrouj; Yueying Liu; Kumar Sambamurti; Craig Crosson

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):3151. doi:

ARVO Annual Meeting Abstract June 2013

A 34-amino acid region of PEDF protects the RPE barrier from VEGF-induced breakdown

Danielle Desjardins; Mohammad Dahrouj; Jason Kenealey; S Patricia Becerra; Yueying Liu; Kumar Sambamurti; Craig Crosson; Zsolt Ablonczy

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1187. doi:

ARVO Annual Meeting Abstract June 2013

AGE products disrupt RPE barrier function in vitro and in vivo

Mohammad Dahrouj; Yueying Liu; Craig Crosson; Zsolt Ablonczy

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1722. doi:

Physiology and Pharmacology June 2013

Inhibition of HDAC2 Protects the Retina From Ischemic Injury

PDF

Jie Fan; Oday Alsarraf; Mohammad Dahrouj; Kenneth A. Platt; C. James Chou; Dennis S. Rice; Craig E. Crosson
TAGS: ischemia, histone deacetylase, wounds and injuries, mice, retina, injury of retina
Invest. Ophthalmol. Vis. Sci.. 2013; 54(6):4072-4080. doi: 10.1167/iovs.12-11529

ARVO Annual Meeting Abstract March 2012

Using SD-OCT to Study the Effect of VEGF on Fluid Transport across the RPE In Vivo

Mohammad Dahrouj; Jake C. McMillin; Craig E. Crosson; Zsolt Ablonczy

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2271. doi:

ARVO Annual Meeting Abstract March 2012

Human Retinal Pigment Epithelium Cells As Functional Models for Retinoid Metabolism

Lucero J. Vivar; Yueying Liu; Patrice Goletz; Mohammad Dahrouj; Peter H. Tang; Zsolt Ablonczy

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4295. doi:

Physiology and Pharmacology November 2011

Human Retinal Pigment Epithelium Cells as Functional Models for the RPE In Vivo

PDF

Zsolt Ablonczy; Mohammad Dahrouj; Peter H. Tang; Yueying Liu; Kumar Sambamurti; Alan D. Marmorstein; Craig E. Crosson
TAGS: vascular endothelial growth factor a, bodily secretions, retinoids, retinal pigment epithelium, retinal pigment cell
Invest. Ophthalmol. Vis. Sci.. 2011; 52(12):8614-8620. doi: 10.1167/iovs.11-8021

ARVO Annual Meeting Abstract April 2011

Natriuretic Peptides Protect the RPE From AGE-Induced Barrier Breakdown

Mohammad Dahrouj; Zsolt Ablonczy; Craig E. Crosson

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5659. doi:

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Association between IOP and retinal thickness following intravitreal triamcinolone injections in DME patients

Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats

The hyperglycemia-induced early retinal pigment epithelium dysfunction is mediated by vascular endothelial growth factor

Acetylation Preserves Retinal Ganglion Cell Structure and Function in a Chronic Model of Ocular Hypertension

RPE barrier dsyfunction is an early complication in the diabetic eye

Trichostatin A abrogates advanced glycation end-product-induced retinal pigment epithelium dysfunction in an in vivo model of diabetic eye disease

Progressive dysfunction of the retinal pigment epithelium and retina due to increased VEGF-A levels

CNP reverses AGE effects on RPE by Acting Downstream from VEGF Release

Vascular Endothelial Growth Factor Modulates the Function of the Retinal Pigment Epithelium In Vivo

Lack of Correlation Between the Spatial Distribution of A2E and Lipofuscin Fluorescence in the Human Retinal Pigment Epithelium

Natriuretic peptides regulate MAP kinases via PKG to protect the RPE from VEGF action

A 34-amino acid region of PEDF protects the RPE barrier from VEGF-induced breakdown

AGE products disrupt RPE barrier function in vitro and in vivo

Inhibition of HDAC2 Protects the Retina From Ischemic Injury

Using SD-OCT to Study the Effect of VEGF on Fluid Transport across the RPE In Vivo

Human Retinal Pigment Epithelium Cells As Functional Models for Retinoid Metabolism

Human Retinal Pigment Epithelium Cells as Functional Models for the RPE In Vivo

Natriuretic Peptides Protect the RPE From AGE-Induced Barrier Breakdown

To View More...

You must be signed into an individual account to use this feature.